All News from Accelerate Diagnostics

All News

Accelr8 Announces First European Presentation of Rapid Diagnostic Results for New Drug Resistance Test

Mar 01, 2011 — Accelr8 Technology Corporation (NYSE Alternext US: AXK) announced that one of its outside principal investigators received acceptance to present results of a new study in Europe.

Continue reading ›

Accelr8 Announces Presentation of Preliminary Results in Pilot ICU Study, Plus Advances in Product Engineering

Feb 22, 2011 — May meeting for Pulmonary Medicine will have a presentation on preliminary results from study at Denver Health with ICU patient specimens. Company also announced start of product engineering to meet early milestones for next product version.

Continue reading ›